Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence

This publication has 18 references indexed in Scilit:

• Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study
  Journal of the American College of Cardiology, 1994
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction
  The American Journal of Cardiology, 1993
• Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction
  The American Journal of Cardiology, 1991
• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
  BMJ, 1988
• A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary Angioplasty
  New England Journal of Medicine, 1987
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
  New England Journal of Medicine, 1986